GlycoRNA-associated miR-1228-3p promotes malignant progression of laryngeal squamous cell carcinoma by targeting SOX17
This study identifies GlycoRNA-associated miR-1228-3p as a novel driver of laryngeal squamous cell carcinoma progression that functions by directly targeting and suppressing SOX17 to activate the Wnt/β-catenin signaling pathway.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Cancer is often understood as a disease of the inside, where cells grow out of control deep within the body. But scientists are increasingly looking at the surface of cells, where a new class of molecules called GlycoRNAs has recently been discovered. These are tiny strands of genetic material, similar to the RNA that carries instructions inside our cells, but they have been decorated with sugar molecules. This sugar coating allows them to stick to the outside of the cell, acting like a visible flag that other cells or the immune system can see. While we know that small genetic switches called microRNAs can turn cancer genes on or off, it was unclear if these sugar-coated versions played a role in how tumors grow and spread. Laryngeal squamous cell carcinoma, a type of cancer affecting the voice box, remains difficult to treat, and researchers are searching for new clues to understand why it becomes so aggressive.
A team of researchers at the Second Affiliated Hospital of Harbin Medical University set out to investigate this connection. They focused on the surface of cancer cells taken from patients with laryngeal cancer to see what genetic signals were present there. Using a method that acts like a magnet to pull out only the sugar-coated genetic strands, they isolated these GlycoRNAs from tumor tissue and compared them to healthy tissue from the same patients. They found a distinct pattern of genetic activity on the surface of the cancer cells that was different from the healthy cells. Among the many signals they detected, one specific genetic switch, known as miR-1228-3p, stood out as being significantly more active in the cancer samples. To ensure this finding was not a fluke, the team checked their results against a large, public database of genetic data from other patients, confirming that this same switch was indeed turned up high in laryngeal cancer cases across different groups.
The researchers then wanted to know what this active switch was actually doing. They treated cancer cells in a dish with an enzyme that eats away at RNA on the cell surface. When they removed these surface genetic signals, the cancer cells lost their ability to invade and spread, and they stopped multiplying as quickly. Crucially, when they added a protective substance that stopped the enzyme from working, the cancer cells returned to their aggressive behavior. This suggested that the sugar-coated genetic material on the surface was actively helping the tumor grow and move. The team then traced the path of this specific switch, miR-1228-3p, to see which gene it was controlling. They discovered that it was targeting a gene called SOX17, which normally acts as a brake to stop cancer cells from growing. In the cancer cells, the high levels of the switch were silencing this brake.
To prove this connection was real, the scientists performed a series of tests in the lab. They showed that the switch physically binds to the instructions for the SOX17 gene, effectively blocking it from working. When they looked at the broader picture of what happens when this gene is blocked, they found that a major signaling pathway known to drive cancer growth, the Wnt pathway, became highly active. This pathway is like a master switch for cell division and movement. The researchers also tested this in living animals by growing human tumors in mice. When they treated these mice with the enzyme to remove the surface signals, the tumors shrank and produced less light in imaging scans, indicating they were less active. However, when they protected the signals with the inhibitor, the tumors continued to grow.
The study concludes that laryngeal cancer cells use these sugar-coated genetic signals on their surface to silence a protective gene, allowing the tumor to grow and spread. While the researchers have not yet tested every possible way to stop this process in patients, their work provides a clear map of how this specific genetic interaction works. They have identified a potential new target for future treatments: if doctors could block this surface signal or restore the protective gene, they might be able to slow down the progression of this difficult cancer. The findings suggest that looking at the surface of cancer cells, rather than just the inside, offers a new and promising way to understand how these tumors behave.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.